Therapeutic bacteriophage compositions
AssigneeArmata Pharmaceuticals, Inc.
InventorsKaren Joy Shaw, Sandra P. Morales, Gillian Mearns, Deborah A. Rankin, Frenk Smrekar
Life of this patent
Estimating the term…
Abstract
The present invention relates to a bacteriophage composition comprising one or more (suitably two or more, or three) bacteriophages selected from Sa87, J-Sa36, Sa83, J-Sa37, or mutants thereof, use of the same for medical or non-medical applications, kits, bandage, and wound dressing comprising the same.
Claims21
A method of treating a Staphylococcus aureus bacterial infection, comprising administering a bacteriophage composition comprising one or more bacteriophages that infect and lyse Staphylococcus aureus selected from Sa87, J-Sa36, and Sa83.
A method of treating a pulmonary bacterial infection in a subject comprising administering a bacteriophage composition comprising one or more bacteriophages that infect and lyse Staphylococcus aureus selected from Sa87, J-Sa36, and Sa83 to the subject, wherein the bacterial infection comprises Staphylococcus aureus.
A method of killing Staphylococcus aureus bacteria on a surface, said method comprising applying a bacteriophage composition comprising one or more bacteriophages that infect and lyse Staphylococcus aureus selected from Sa87, J-Sa36, and Sa83 to the surface.
A non-medical method of killing Staphylococcus aureus bacteria comprising applying to a food product or a crop a bacteriophage composition comprising one or more bacteriophages that infect and lyse Staphylococcus aureus selected from Sa87, J-Sa36, and Sa83.
Dependencies are inferred from the claim text.